XTL Biopharmaceuticals Ltd. - Payout Ratio History
Payout ratio history for stock XTLB (XTL Biopharmaceuticals Ltd.).
| Date | Payout ratio |
|---|---|
| December 2020 | -304.66% |
| November 2020 | -231.44% |
| October 2020 | -231.44% |
| September 2020 | -231.44% |
| August 2020 | -156.80% |
| July 2020 | -156.80% |
| June 2020 | -156.80% |
| May 2020 | -2705.63% |
| April 2020 | 208.33% |
| March 2020 | 208.33% |
| February 2020 | 208.33% |
| January 2020 | 208.33% |
| December 2019 | 208.33% |
| November 2019 | 208.33% |
| October 2019 | 208.33% |
| September 2019 | 208.33% |
| August 2019 | 208.33% |
| July 2019 | 208.33% |
| June 2019 | 208.33% |
| May 2019 | 208.33% |
| April 2019 | 208.33% |
| March 2019 | -625% |
| February 2019 | -625% |
| December 2018 | -625% |
XTLB
Price: $2.56
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.40 USD
P/E Ratio: -2.29
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 5727
Ebitda: -1.4 millionMarket Capitalization: 15.0 million